Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 83, Issue 6, Pages 909-912Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2008.52
Keywords
-
Categories
Funding
- NIGMS NIH HHS [GM 57980, R01 GM057980-10, R01 GM057980] Funding Source: Medline
Ask authors/readers for more resources
Contemporary models in the field of pharmacokinetic-pharmacodynamic (PK-PD) modeling often incorporate the fundamental principles of capacity limitation and operation of turnover processes to describe the time course of pharmacological effects in mechanistic terms. This permits the identification of drug- and system-specific factors that govern drug responses. There is considerable interest in utilizing mechanism-based PK-PD models in translational pharmacology, whereby in silico, in vitro, and preclinical data may be effectively coupled with relevant models to streamline the discovery and development of new therapeutic agents. These translational PK-PD models form the subject of this review.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available